Cargando…
Metformin in the Treatment of Amisulpride-Induced Hyperprolactinemia: A Clinical Trial
OBJECTIVE: To evaluate the efficacy and safety of metformin in the treatment of amisulpride-induced hyperprolactinemia. METHODS: A total of 86 schizophrenic patients who developed hyperprolactinemia after taking amisulpride were screened and randomly assigned to the metformin group (42 patients) and...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205636/ https://www.ncbi.nlm.nih.gov/pubmed/35721320 http://dx.doi.org/10.3389/fnmol.2022.892477 |